Related Experiment Video
Updated: Mar 21, 2026
09:02
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.5K
[Devastating surgical complications after aflibercept chemotherapy]
Estíbaliz Echazarreta-Gallego1, Manuela Elía-Guedea1, Elena Córdoba-Díaz de Laspra1
1Sección de Coloproctología, Servicio de Cirugía General, Hospital Clínico Universitario de Zaragoza, Zaragoza, España.
Cirugia Y Cirujanos
|May 4, 2016
Summary
A patient experienced a fatal intestinal perforation and hemorrhage after receiving antiangiogenic therapy for colorectal cancer. This highlights the severe complications associated with these treatments.
Area of Science:
- Oncology
- Gastroenterology
- Pharmacology
Background:
- Adjuvant chemotherapy for colorectal cancer can lead to serious complications.
- Monoclonal antibodies used in treatment are linked to bleeding and intestinal perforations.
Observation:
- A 42-year-old male with metastatic rectal cancer underwent surgery.
- Sixteen months post-surgery, during second-line adjuvant therapy, he developed intestinal perforation with hemorrhage.
Findings:
- The patient suffered an intestinal leak to the retroperitoneum and left lower extremity.
- Despite intensive medical and surgical interventions, the complication was fatal.
Implications:
- Further research is needed to identify biomarkers for targeted antiangiogenic agent use.
- This could help reduce adverse events and improve patient outcomes in colorectal cancer treatment.
